Literature DB >> 32451344

Are patients with systemic lupus erythematosus at increased risk for COVID-19?

Ennio Giulio Favalli1, Maria Gerosa2,3, Antonella Murgo2, Roberto Caporali2,3.   

Abstract

Entities:  

Keywords:  antirheumatic agents; hydroxychloroquine; lupus erythematosus, systemic

Year:  2020        PMID： 32451344     DOI： 10.1136/annrheumdis-2020-217787

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  17 in total

Review 1.  Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management.

Authors:  Pankti Mehta; Armen Yuri Gasparyan; Olena Zimba; George D Kitas
Journal:  Clin Rheumatol       Date:  2022-05-31       Impact factor: 3.650

2.  Does autoimmune vitiligo protect against COVID-19 disease?

Authors:  Nicoline F Post; Rosalie M Luiten; Albert Wolkerstorfer; Marcel W Bekkenk; Markus Böhm
Journal:  Exp Dermatol       Date:  2021-06-17       Impact factor: 4.511

Review 3.  SARS-CoV-2 and Systemic Lupus Erythematosus.

Authors:  Aikaterini Thanou; Amr H Sawalha
Journal:  Curr Rheumatol Rep       Date:  2021-01-28       Impact factor: 4.592

Review 4.  COVID-19 illness and autoimmune diseases: recent insights.

Authors:  Juan Li; Hong-Hui Liu; Xiao-Dong Yin; Cheng-Cheng Li; Jing Wang
Journal:  Inflamm Res       Date:  2021-02-28       Impact factor: 4.575

Review 5.  COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease.

Authors:  Ruth Fernandez-Ruiz; Jacqueline L Paredes; Timothy B Niewold
Journal:  Transl Res       Date:  2020-12-19       Impact factor: 7.012

6.  COVID-19 in Italian Sjögren's syndrome patients: a monocentric study.

Authors:  F Giardina; R Izzo; A Gattamelata; S Colafrancesco; F Conti; R Priori
Journal:  Rheumatol Int       Date:  2020-10-18       Impact factor: 2.631

7.  BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus.

Authors:  Quentin Moyon; Delphine Sterlin; Makoto Miyara; François Anna; Guy Gorochov; Zahir Amoura; Alexis Mathian; Raphael Lhote; Pascale Ghillani-Dalbin; Paul Breillat; Sasi Mudumba; Sophia de Alba; Fleur Cohen-Aubart; Julien Haroche; Micheline Pha; Thi Huong Du Boutin; Hedi Chaieb; Pedro Macedo Flores; Pierre Charneau
Journal:  Ann Rheum Dis       Date:  2021-10-04       Impact factor: 19.103

8.  Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt.

Authors:  Nevin Hammam; Samar Tharwat; Rawhya R El Shereef; Ahmed M Elsaman; Noha M Khalil; Hanan M Fathi; Mohamed N Salem; Hanan M El-Saadany; Nermeen Samy; Amany S El-Bahnasawy; Yousra H Abdel-Fattah; Marwa A Amer; Emad ElShebini; Amira T El-Shanawany; Dina H El-Hammady; Rasha Abdel Noor; Marwa ElKhalifa; Faten Ismail; Rasha M Fawzy; Amany R El-Najjar; Zahraa I Selim; Nouran M Abaza; Ahmed R Radwan; Mervat IAbd Elazeem; Wael Abdel Mohsen; Abdel Hafeez Moshrif; Eman F Mohamed; Loay I Aglan; Soha Senara; Maha E Ibrahim; Iman Khalifa; Rasha El Owaidy; Noha El Fakharany; Reem Hamdy A Mohammed; Tamer A Gheita
Journal:  Rheumatol Int       Date:  2021-07-09       Impact factor: 2.631

Review 9.  Chloroquine and hydroxychloroquine for COVID-19: Perspectives on their failure in repurposing.

Authors:  Rashmi R Shah
Journal:  J Clin Pharm Ther       Date:  2020-09-27       Impact factor: 2.145

Review 10.  COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies.

Authors:  Renuka Raman; Krishna J Patel; Kishu Ranjan
Journal:  Biomolecules       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.